StockWatch
·

ACC LTD. Q1 FY27 Results

ACCQ1 FY27 Results
Filing
Result:Poor· Market: FlatMargin squeezeOne-off hit

Beat/Miss: Miss · Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValueQ4 FY26Q1 FY26
Revenue5.8K Cr18.7%4.6%
Total Income5.9K Cr18.6%4.8%
Expenditure5.6K Cr17.4%0.8%
PBT198.00 Cr46.2%64.7%
Net Profit147.00 Cr38.3%60.8%
OPM7.46%1.25pp5.32pp
NPM2.51%0.80pp3.59pp
EPS7.8338.3%60.8%
View full financials

Core sector metric (cement volumes/revenue) fell YoY with sharp operating margin compression (~12.8%→~8%), adjusted PAT down ~56% and a sharp miss vs street estimates, meeting the poor-band bar for clear deterioration.

ACC · Q1 FY27 · THE VERDICT

Cost Leadership Can't Mask Demand Rout; 12% H2 Growth Now Required

Ambuja delivered ₹206 per tonne in sequential cost savings and EBITDA margin jumped 331 bps. Volumes fell 7% YoY anyway. The bet that cost discipline can offset pricing weakness just shifted the entire FY27 growth burden to H2.

03 Aug 2026 · 6 min read
Reported Revenue

₹9,500 Cr

Consolidated (post-acquisition)

Reported PAT

₹660 Cr

Includes RE & fly-ash sales benefit

EBITDA margin

16.7%

+331 bps QoQ

Cement volumes YoY

-7%

Trade -2% | Non-trade -21%

Cost/ton

₹4,241

QoQ -₹206; FY27 target ₹4,250

Capacity utilization

65%

Deliberately depressed (value-focused strategy)

The core tension: cost discipline is genuine and accelerating (₹206/ton QoQ, on track for ₹4,250 FY27), but volume weakness is real and worsening (volumes -7% YoY despite premium mix focus). Management reaffirmed 8% full-year growth guidance, which now requires 12%+ growth in the remaining nine months to recoup Q1's miss. Pricing power appears absent (net selling price flat QoQ despite trade mix gains, down ₹100/ton YoY vs. UltraTech). The bet is that cost leadership alone can drive re-rating; the call exposed how thin that margin of safety has become.

What the quarter actually reveals

Ambuja is executing a deliberate strategy shift: exit non-trade (low-margin B2B), slash 3.5 MT of old capacity, and harvest cost savings from the integration of acquired assets (Penna, Sanghi, Orient). The 78% trade mix (up from 74%) and 34% premium product share are the ploys. EBITDA/ton of ₹931 looks exceptional, but earnings quality flags surface: RE power sales of ₹140 Cr are feeding EBITDA at inflated spreads vs. grid rates (transition to internal consumption by Q2 will halve the benefit). Fly ash sales of ₹15 Cr (down sharply from ₹50 Cr in Q4) are normalizing too. Adjust for these, and core cement EBITDA is solid but not spectacular.

We are already seeing an 8% improvement on the trade volumes… I think what we are confident is the whole brand pool and the trade segment and the premium actually is going to differentiate our price movement also.
Management's claims vs. what the data supports

₹206/ton cost save despite 12% kiln maintenance

Supported — achieved ₹4,241 from ~₹4,447 Q4, absorbing ₹110/ton West Asia headwind.

Trade volumes growing; 8% July growth already achieved

Partial — Q1 trade down 2% YoY. July claim unverified; tone suggests Q1 was trough but no hard data.

8% volume growth for full-year FY27 is on track

Overstated — requires 12%+ growth in next 9 months after -7% Q1. Monsoon-dependent, unproven.

EBITDA per ton ₹931 reflects operational excellence

Supported but inflated — partly driven by ₹206/ton cost save via capacity suspension (3.5 MT offline), not all structural.

What changed this quarter

  • Volume strategy: Deliberately exiting low-margin non-trade (down 21% YoY); suspended 3.5 MT of old ACC Chaibasa, Marwar, Wadi, Lakheri + one acquired asset for 6-month optimization.

  • Cost guidance: Reaffirmed ₹4,250/ton for FY27; achieved ₹4,241 in Q1 despite ₹110/ton geopolitical headwind.

  • Growth guidance: 8% FY27 volume growth reaffirmed despite -7% Q1 (management bet on H2 monsoon + brand momentum recovery).

  • RE power transition: Ramping to 50% internal consumption by Q2 (currently 45 Cr units sold at ₹3.1/unit cost). Will save ₹100+/ton vs. external purchase but halves current revenue benefit.

  • Capex timeline: Maratha clinker line pushed from FY27 to Q1 FY28 (1-quarter slip); Jodhpur, Kalamboli, Warisaliganj on track for Q2 FY27 commissioning.

The bull-bear ledger

  • Cost transformation is real and accelerating: ₹206/ton QoQ save, on track for ₹4,250 FY27 target.

  • Capacity expansion ahead: 10.2 MT net adds by FY27-end; 119 MT capacity roadmap 2027–2029 provides scale advantage.

  • RE power ramp (973 MW, path to 1,122 MW) creates structural cost moat; ₹100+/ton savings trajectory FY26–FY28.

  • Trade mix & premium focus (78% trade, 34% premium) position for price realization as brand equity grows.

  • Volume guidance (8% FY27) is at risk; requires 12%+ H2 growth after -7% Q1 and two straight quarters of decline.

  • Pricing power missing: NSP flat QoQ despite premium mix gains; ₹100/ton below UltraTech YoY suggests structural discount, not temporary disruption.

  • Capacity suspension (3.5 MT) introduces stranded asset/impairment risk if macro doesn't recover in H2.

  • Cost savings partly unsustainable: RE power sales phase to internal consumption; capacity suspension effects roll off; geopolitical headwind (₹110/ton absorbed, ₹100/ton more at risk).

Ranked risks — what should concern a holder

Volume recovery is faith-based, not proven

High

8% FY27 guidance requires 12%+ H2 growth after -7% Q1. July 8% trade growth is anecdotal & unverified. No new demand catalyst named; relies on monsoon & brand momentum (unproven).

Pricing power structural, not cyclical

High

NSP down ₹100 YoY vs. UltraTech despite premium mix focus; deflection to 'accounting treatment' & 'Q1 disruption' suggests structural competitive weakness, not temporary.

Capacity suspension impairment

Medium

3.5 MT offline (Chaibasa, Marwar, Wadi, Lakheri + 1 acquired). 6-month timeline; if demand stays soft, permanent closure & write-down likely. Management denies impairment but optionality is shrinking.

Geopolitical input cost escalation

Medium

₹110/ton absorbed in Q1. Management holds ₹100-150/ton of cushion (inventory buffer) but further escalation could derail ₹4,250 target & margin guidance.

Capex execution delays

Medium

Maratha pushed 1 quarter (FY27→FY28); Mundra delayed to 2029. Mixed track record; delays push capacity ramps and cost reductions downstream.

RE power benefit normalizes

Medium

₹140 Cr power sales revenue at ₹3.1/unit cost (selling ~₹7+/unit) flow to EBITDA. Transition to 50% internal consumption by Q2 will halve this benefit; ₹70-80 Cr one-time EBITDA roll-off.

RMC segment deterioration unexplained

Low

EBITDA margin collapsed to 7% from 14–15% (blamed on raw material & lease accounting). No detail; suggests segment weakness or accounting mask. Small but transparency red flag.

How the street is positioned

Stock rose 1.28% day-1 post-result (delivery 64.5%), held gains to +2.23% by day-3, now off 1% from there. The price action is telling: the pop was modest and immediately faded, suggesting the street was not surprised by either the cost discipline or the volume miss. This is a 'hold tight, wait and see' market.

Current price

₹1,398

as of 2026-08-03

vs. 52-week low

+11.66%

₹1,252 low

vs. All-time high

-29.64%

₹1,987 ATH

vs. SMA50

+2.9%

₹1,359 / holds above

vs. SMA200

-10.4%

₹1,561 / below

RSI

58.1

Neutral (not overbought)

The 30% discount to all-time high reflects justified caution: cost story is real but doesn't buy volume recovery. Ownership is stable (promoter 56.69%, DII 21.61%, FII 5.93%) with no signs of institutional capitulation or enthusiasm — FII actually trimmed 6 bps QoQ, suggesting global funds are not convinced on the turnaround yet. Volume is normal; no block/bulk activity flags insider selling near resistance.

The debate

The honest read: Cost discipline is real and management execution is solid, but the bull case is entirely dependent on Q2/H2 demand recovery that remains unproven. Pricing weakness despite mix improvement suggests a structural competitive disadvantage vs. UltraTech, not a temporary disruption. The 8% FY27 growth target is achievable if monsoon demand materializes and industry stabilizes above 5%, but management has provided no new catalyst beyond weather and brand momentum — thin reassurance after two quarters of volume decline. The stock's 30% discount to ATH is justified; hold off adding until volume trends turn positive YoY in Q2.

What to watch next

  • 1 · Q2 FY27 volume trends (Sep 2026 print)

    Do trade volumes turn positive YoY? July 8% anecdote is unverified; Q2 actual data will confirm or refute demand recovery narrative. Volume growth is the single validation needed for 8% FY27 guidance credibility.

  • 2 · NSP realization and mix improvement (Q2 ongoing)

    Does premium product mix (34% of trade) drive NSP recovery in a better market? Or does ₹100/ton discount vs. UltraTech persist, confirming structural pricing weakness? Price ladder expansion is the missing link in the margin story.

  • 3 · New capacity commissioning on schedule (Q2 FY27)

    Jodhpur clinker, Kalamboli, Warisaliganj expected Q2 start; Maratha now Q1 FY28 (1-quarter slip absorbed). Execution matters: delays push cost reduction roadmap downstream. Watch for actual commissioning dates vs. guidance.

  • 4 · Geopolitical input cost trajectory (ongoing)

    West Asia escalation hit ₹110/ton in Q1; management guided ₹100–150/ton further headwind risk (mitigated by inventory buffer). Monitor clinker/fuel markets; if escalation continues, cost target ₹4,250 at risk.

  • 5 · Acquired asset integration pace (Q2–Q3 FY27)

    Penna, Sanghi channel buildout on track for 1–2 quarter ramps (per mgmt). Orient MSA payouts sustainable? Margin expansion on integrated assets will confirm turnaround story or expose hidden weakness.

Ambuja has executed cost discipline in a soft quarter; that's real and deserves recognition. ₹206/ton saved, EBITDA margin expanded 331 bps, cost guidance reaffirmed — the operational story is solid. But demand weakness is equally real, and the 8% FY27 growth guidance is a bet, not a fact. The stock's 30% discount to all-time high reflects this honestly: cost alone can't drive re-rating without volume proof.

The next two quarters are pivot points. If Q2 volume trends turn positive YoY and monsoon demand pickup validates the H2 narrative, the stock re-rates toward ₹1,600–₹1,750. If volumes stay negative and pricing remains flat, the cost story exhausts and margins compress. For now, the verdict is Hold; the number to track is trade volume growth (positive or negative YoY in Q2). Reprieve is not an invitation to add; clarity is required first.

Informational and educational content only. Not investment advice.